Innovation

Fake medication and compromised devices are part of a global market that poses a significant threat to the health of patients. Here’s how the company’s Global Brand Protection team helps keep people safe.

Justin and Colin Farlow share how their next-generation cell and gene therapies are helping Johnson & Johnson in its quest to get in front of cancer.

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.

Meet Xiao-Yu Song, Global Head of Research & Development for Vision at Johnson & Johnson, who leads a talented team that creates cutting-edge products addressing vision problems through all stages of life.

Learn the latest about this common procedure and how Johnson & Johnson MedTech is innovating to improve patient outcomes.

Elisa Glass was diagnosed with dermatomyositis, which causes severe muscle weakness throughout the body. Learn more about the disease and how Johnson & Johnson is working to develop a treatment to help Glass and other patients like her.

The need for these rare disease therapies is strong, and access to them can be lifesaving. Here’s how Johnson & Johnson is innovating to help give patients options.

A treatment for an incurable cancer. Catheters to better diagnose and treat AFib. A surgical stapler that’s easier to use. These are just some of the Johnson & Johnson advances that are helping improve the health of people everywhere.

Every year, the company bestows this honor on outstanding scientists or researchers whose perseverance makes medical innovation and advancement possible.

Climate change is intertwined with just about every industry worldwide, including healthcare. For Earth Day, here’s a look at how Johnson & Johnson is taking action to help support a healthy planet.